{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:32:51Z","timestamp":1770186771935,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Merck Sharp and Dohme"},{"name":"The French Society of Rheumatology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate whether serum Col 3\u20134, a new biochemical marker of synovial tissue turnover, was associated with progression of joint damage in patients with early arthritis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 788 early arthritis patients (&amp;lt;6 months of symptoms, 82% diagnosis of RA, 18% undifferentiated arthritis) from the prospective ESPOIR study were investigated. Progression was defined as an increase of 1 or 5 unit(s) in radiographic van der Heijde modified Sharp score between baseline and 1 or 5\u2009years, respectively. Associations between baseline Col 3\u20134 and progression were assessed by logistic regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Each standard deviation increase of baseline Col 3\u20134 levels was associated with an increased 5-yr total damage progression with an odds ratio (OR, 95% CI) of 1.51 (1.21, 1.88), which remained significant when DAS28, C-reactive protein and anti-citrullinated protein antibodies positivity were included in the model [OR (95% CI): 1.34 (1.01, 1.76)]. Further adjustment for bone erosion did not modify the association. Patients with both Col 3\u20134 in the highest quintile and bone erosion had a &amp;gt;2-fold higher risk of progression [OR (95% CI): 7.16 (2.31, 22)] than patients with either high Col 3\u20134 [2.91 (1.79, 4.73)] or bone erosion [2.36 (2.38, 3.70)] alone. Similar associations were observed for prediction of 12\u2009months progression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Increased serum Col 3\u20134 is associated with a higher risk of structural progression, independently of major risk factors. Col 3\u20134 may be useful in association with bone erosion to identify patients with early arthritis at higher risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead375","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T19:04:46Z","timestamp":1689879886000},"page":"874-881","source":"Crossref","is-referenced-by-count":3,"title":["A new serum biochemical marker of synovium turnover predicts radiographic progression in patients with early arthritis"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-5099","authenticated-orcid":false,"given":"Patrick","family":"Garnero","sequence":"first","affiliation":[{"name":"INSERM, UMR1033, H\u00f4pital Edouard Herriot, Pavillon F , Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Gineyts","sequence":"additional","affiliation":[{"name":"INSERM, UMR1033, H\u00f4pital Edouard Herriot, Pavillon F , Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Rousseau","sequence":"additional","affiliation":[{"name":"INSERM, UMR1033, H\u00f4pital Edouard Herriot, Pavillon F , Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris 7, UFR M\u00e9dicale, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Lariboisi\u00e8re, F\u00e9d\u00e9ration de Rhumatologie , Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[{"name":"INSERM, UMRS 938, service de rhumatologie, Sorbonne Universit\u00e9, H\u00f4pital Saint-Antoine, AP-HP , Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[{"name":"INSERM, UMR1033, H\u00f4pital Edouard Herriot, Pavillon F , Lyon, France"},{"name":"Hospices Civils de Lyon, H\u00f4pital Edouard Herriot , Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2024030205494409400_kead375-B1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","article-title":"Rheumatoid arthritis: pathophysiology and implications for therapy","volume":"322","author":"Harris","year":"1990","journal-title":"N Engl J Med"},{"key":"2024030205494409400_kead375-B2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2024030205494409400_kead375-B3","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"2024030205494409400_kead375-B4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/1874312901105010107","article-title":"The synovium in rheumatoid arthritis","volume":"5","author":"Hitchon","year":"2011","journal-title":"Open Rheumatol J"},{"key":"2024030205494409400_kead375-B5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/oxfordjournals.rheumatology.a031490","article-title":"Prognostic factors in early rheumatoid arthritis","volume":"39(Suppl 1)","author":"Scott","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"2024030205494409400_kead375-B6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/rheumatology\/35.11.1106","article-title":"Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort","volume":"35","author":"Fex","year":"1996","journal-title":"Br J Rheumatol"},{"key":"2024030205494409400_kead375-B7","first-page":"S54","article-title":"Biochemical markers of joint tissue turnover in early rheumatoid arthritis","volume":"21","author":"Garnero","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2024030205494409400_kead375-B8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.2004.035196","article-title":"Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis","volume":"65","author":"Landew\u00e9","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2024030205494409400_kead375-B9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/rheumatology\/kez647","article-title":"The role of biochemical markers of joint tissue remodelling to predict progression and treatment efficacy in inflammatory rheumatic diseases","volume":"59","author":"Garnero","year":"2020","journal-title":"Rheumatology (Oxford)."},{"key":"2024030205494409400_kead375-B10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/ard.2010.129304","article-title":"Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis","volume":"70","author":"Freeston","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024030205494409400_kead375-B11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3899\/jrheum.090262","article-title":"Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers","volume":"36","author":"Syversen","year":"2009","journal-title":"J Rheumatol"},{"key":"2024030205494409400_kead375-B12","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/art.10616","article-title":"Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2024030205494409400_kead375-B13","first-page":"31","article-title":"Changes in the collagen of synovial membrane in rheumatoid arthritis and effect of D-penicillamine","volume":"55","author":"Lovell","year":"1978","journal-title":"Clin Sci Mol Med"},{"key":"2024030205494409400_kead375-B14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.54.5.404","article-title":"Extracellular matrix of the synovial intimal cell layer","volume":"54","author":"Revell","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"2024030205494409400_kead375-B15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0006-291X(75)80471-2","article-title":"Occurrence of type III collagen in inflamed synovial membranes: a comparison between non rheumatoid, rheumatoid, and normal synovial collagens","volume":"65","author":"Weiss","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"2024030205494409400_kead375-B16","doi-asserted-by":"crossref","first-page":"e0282954","DOI":"10.1371\/journal.pone.0282954","article-title":"Serum Col3-4: a new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis","volume":"18","author":"Gineyts","year":"2023","journal-title":"PLoS One"},{"key":"2024030205494409400_kead375-B17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jbspin.2007.06.001","article-title":"The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients","volume":"74","author":"Combe","year":"2007","journal-title":"Joint Bone Spine"},{"key":"2024030205494409400_kead375-B18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","article-title":"EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"66","author":"Combe","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2024030205494409400_kead375-B19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2024030205494409400_kead375-B20","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2024030205494409400_kead375-B21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"2024030205494409400_kead375-B22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s100670050006","article-title":"Prediction of creatinine clearance from serum creatinine in patients with rheumatoid arthritis: comparison of six formulae and one nomogram","volume":"19","author":"Anders","year":"2000","journal-title":"Clin Rheumatol"},{"key":"2024030205494409400_kead375-B23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(89)92442-2","article-title":"Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis","volume":"1","author":"van der Heijde","year":"1989","journal-title":"Lancet"},{"key":"2024030205494409400_kead375-B24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/ard.2010.144402","article-title":"Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis","volume":"70","author":"Mouterde","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024030205494409400_kead375-B25","doi-asserted-by":"crossref","first-page":"R210","DOI":"10.1186\/ar4404","article-title":"Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort","volume":"15","author":"Meyer","year":"2013","journal-title":"Art Res Ther"},{"key":"2024030205494409400_kead375-B26","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/srep18421","article-title":"Increased Dickkopf-1 in recent onset rheumatoid arthritis is a new biomarker of structural severity. Data from the ESPOIR cohort","volume":"6","author":"Seror","year":"2016","journal-title":"Sci Rep"},{"key":"2024030205494409400_kead375-B27","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/annrheumdis-2017-212869","article-title":"Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on \u2018Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis\u2019 by Jonsson et al","volume":"77","author":"Jonsson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024030205494409400_kead375-B28","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024030205494409400_kead375-B29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"key":"2024030205494409400_kead375-B30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q","article-title":"Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead375\/51088957\/kead375.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/3\/874\/56818721\/kead375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/3\/874\/56818721\/kead375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T05:50:24Z","timestamp":1709358624000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/3\/874\/7227067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,7,20]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead375","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,7,20]]}}}